4/A: Inari Medical Director Robert Warner Amends Form 4 to Include Power of Attorney

Director Robert Warner amends a previous Form 4 filing to include a Power of Attorney, related to restricted stock units.

Summary

• Robert Warner, a director at Inari Medical, Inc., filed an amended Form 4 with the SEC.
• The amendment, filed on May 31, 2024, updates a previous filing from April 26, 2024.
• The update includes a Power of Attorney granted to an attorney-in-fact.
• The original transaction reported was the acquisition of 4,126 shares of common stock on April 24, 2024, at a price of $42.41 per share.
• These shares represent restricted stock units that vest in full on the earlier of the day prior to the company's next annual meeting or one year from the grant date.
• Following the transaction, Warner beneficially owns 12,149 shares of Inari Medical stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, indicating a neutral sentiment.

Future Outlook

The restricted stock units will vest within one year, potentially impacting Warner's holdings and future filings.

Industry Context

Form 4 filings are standard practice for company insiders to report transactions in their company's stock, ensuring transparency and compliance with SEC regulations.

Key Dates